Evidence map›Paper›PMID 40353915›Full record

ArticleClinical and experimental medicine2025

Risk characteristics of papillary thyroid cancer > 1-4 cm is associated with increased tumour size.

Agnieszka Walczyk, Danuta Gąsior-Perczak, Iwona Pałyga, Janusz Kopczyński, Artur Kuchareczko, Emilia Niedziela, Agnieszka Suligowska, Izabela Płachta, Magdalena Chrapek, Stanisław Góźdź and 1 more

Abstract read
In one paragraph

Article in Clinical and experimental medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Agnieszka WalczykCollegium Medicum, Jan Kochanowski University, Kielce, Poland. a.walczyk@post.pl.ORCID http://orcid.org/0000-0002-5083-659X
Danuta Gąsior-PerczakCollegium Medicum, Jan Kochanowski University, Kielce, Poland.ORCID http://orcid.org/0000-0003-0936-4890
Iwona PałygaCollegium Medicum, Jan Kochanowski University, Kielce, Poland.ORCID http://orcid.org/0000-0001-5333-6112
Janusz KopczyńskiDepartment of Pathology, Holycross Cancer Centre, Kielce, Poland.
Artur KuchareczkoCollegium Medicum, Jan Kochanowski University, Kielce, Poland.ORCID http://orcid.org/0000-0002-2877-5145
Emilia NiedzielaCollegium Medicum, Jan Kochanowski University, Kielce, Poland.ORCID http://orcid.org/0009-0009-5481-8071
Agnieszka SuligowskaEndocrinology Clinic of Holycross Cancer Centre, Stefana Artwińskiego Street 3, 25-734, Kielce, Poland.ORCID http://orcid.org/0000-0002-9224-4066
Izabela PłachtaEndocrinology Clinic of Holycross Cancer Centre, Stefana Artwińskiego Street 3, 25-734, Kielce, Poland.
Magdalena ChrapekFaculty of Natural Sciences, Jan Kochanowski University, Kielce, Poland.ORCID http://orcid.org/0000-0003-2480-6124
Stanisław GóźdźCollegium Medicum, Jan Kochanowski University, Kielce, Poland.ORCID http://orcid.org/0000-0001-6902-3807
Aldona KowalskaCollegium Medicum, Jan Kochanowski University, Kielce, Poland.ORCID http://orcid.org/0000-0001-5647-5898

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Recent guidelines recommend total thyroidectomy for papillary thyroid cancers (PTC) larger than 4 cm. For papillary macrocarcinoma with a diameter >1-4 cm, less intensive surgery can be managed, but this is still a matter for debate. The aim of our study was to assess the prevalence of risk factors such as vascular invasion, positive margin, extrathyroidal extension, aggressive histology, lymph nodes and distant metastases associated with a primary PTC tumour with a diameter >1-4 cm, and the association between tumour size and the risk of having one or more of these factors. A retrospective analysis of the medical records of 857 patients who underwent total thyroidectomy between 2000 and 2020, with a final post-operative diagnosis of a PTC >1-4 cm. Overall, less than a half (47.0%) of tumours were associated with at least one risk factor. The prevalence of analysed risk factors, except aggressive histology and a positive margin status, was significantly associated with larger tumour size (>2-4 cm). The optimal cut-off value for a cumulative risk of having one or more risk factors was estimated as 2.0 cm. Patients with a primary tumour < 2.0 cm had almost double less risk (p-value < 0.0001; OR 1.95; 95% CI 1.47-2.58) of having one or more risk factors than patients with PTC ≥ 2.0 cm. In an era of de-escalation, the cut-off value of 2 cm can be helpful in identifying patients with PTC >1-4 cm and lower risk of having aggressive disease providing less extensive treatment approach.

Indexed as

Thyroid Cancer, PapillaryThyroid NeoplasmsTumor BurdenAdultAgedFemaleHumansMaleMiddle AgedRetrospective StudiesRisk FactorsThyroidectomyYoung AdultDiameter cut-offPapillary thyroid cancerRisk featuresTumour size > 1–4 cm

Identifiers

PMID40353915
PMCPMC12069152

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.